Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma × Aminolevulinic Acid × 1 year × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 6 Keratosis, Actinic 5 Brain Neoplasms 5 Glioma 4 Skin Diseases 2 Precancerous Conditions 2 Neoplasms 2 Carcinoma, Basal Cell 2 Skull Base Neoplasms 1 Sarcoma 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Neurofibromatosis 1 1 Neurofibroma 1 Kidney Neoplasms 1 Head and Neck Neoplasms 1 Breast Neoplasms 1 Astrocytoma 1

Interventions

Doxorubicin 21 pembrolizumab 19 Radiotherapy 16 Magnetic Resonance Spectroscopy 14 Nivolumab 13 Cyclophosphamide 13 Specimen Handling 12 Ifosfamide 10 Gemcitabine 10 Biopsy 10 Surgical Procedures, Operative 9 pazopanib 8 Ipilimumab 8 Blood Specimen Collection 8 X-Rays 7 Trabectedin 7 Temozolomide 7 Radiation 7 fludarabine 6 tazemetostat 5 olaparib 5 eribulin 5 cabozantinib 5 Standard of Care 5 Phantoms, Imaging 5 Irinotecan 5 talimogene laherparepvec 4 fludarabine phosphate 4 atezolizumab 4 abemaciclib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07038278 2026-02-27

5-ALARMS

University of Colorado, Denver

Phase EARLY_PHASE1 Not yet recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡